HEADER TRANSFERASE 24-SEP-15 5AR4 TITLE RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH SB-203580 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 1-310; COMPND 5 SYNONYM: CARD-CONTAINING INTERLEUKIN-1 BETA-CONVERTING ENZYME- COMPND 6 ASSOCIATED KINASE, CARD-CONTAINING IL-1 BETA ICE-KINASE, RIP-LIKE- COMPND 7 INTERACTING CLARP KINASE, RECEPTOR-INTERACTING PROTEIN 2, RIP-2, COMPND 8 TYROSINE-PROTEIN KINASE RIPK2; COMPND 9 EC: 2.7.10.2, 2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, KINASE DOMAIN, KINASE INHIBITOR, STRUCTURE-BASED DRUG KEYWDS 2 DESIGN, INHIBITOR SELECTIVITY EXPDTA X-RAY DIFFRACTION AUTHOR A.K.CHARNLEY,M.A.CONVERY,A.LAKDAWALA SHAH,E.JONES,P.HARDWICKE, AUTHOR 2 A.BRIDGES,B.J.VOTTA,P.J.GOUGH,R.W.MARQUIS,J.BERTIN,L.CASILLAS REVDAT 3 10-JAN-24 5AR4 1 REMARK REVDAT 2 09-DEC-15 5AR4 1 JRNL REVDAT 1 21-OCT-15 5AR4 0 JRNL AUTH A.K.CHARNLEY,M.A.CONVERY,A.LAKDAWALA SHAH,E.JONES, JRNL AUTH 2 P.HARDWICKE,A.BRIDGES,M.OUELLETTE,R.TOTORITIS,B.SCHWARTZ, JRNL AUTH 3 B.W.KING,D.D.WISNOSKI,J.KANG,P.M.EIDAM,B.J.VOTTA,P.J.GOUGH, JRNL AUTH 4 R.W.MARQUIS,J.BERTIN,L.CASILLAS JRNL TITL CRYSTAL STRUCTURES OF HUMAN RIP2 KINASE CATALYTIC DOMAIN JRNL TITL 2 COMPLEXED WITH ATP-COMPETITIVE INHIBITORS: FOUNDATIONS FOR JRNL TITL 3 UNDERSTANDING INHIBITOR SELECTIVITY. JRNL REF BIOORG.MED.CHEM. V. 23 7000 2015 JRNL REFN ISSN 0968-0896 JRNL PMID 26455654 JRNL DOI 10.1016/J.BMC.2015.09.038 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 29550 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1500 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.79 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2862 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2052 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2729 REMARK 3 BIN R VALUE (WORKING SET) : 0.2023 REMARK 3 BIN FREE R VALUE : 0.2666 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.65 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4482 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.46 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.53210 REMARK 3 B22 (A**2) : -5.53210 REMARK 3 B33 (A**2) : 11.06410 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.293 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.328 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.232 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.322 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.234 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4658 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6339 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1580 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 106 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 663 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4658 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 603 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5497 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.17 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AR4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290065147. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.972 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29594 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.70 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.90 REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2EVA REMARK 200 REMARK 200 REMARK: MR MODEL WAS A SUPERPOSITION OF 2EVA, 1U59 AND 3D4Q REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS HCL PH8.5, 0.7M REMARK 280 DINH4TARTRATE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.26933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.63467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.63467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 71.26933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -15 REMARK 465 ASP A -14 REMARK 465 TYR A -13 REMARK 465 LYS A -12 REMARK 465 ASP A -11 REMARK 465 ASP A -10 REMARK 465 ASP A -9 REMARK 465 ASP A -8 REMARK 465 LYS A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 GLY A 3 REMARK 465 GLU A 4 REMARK 465 ILE A 51 REMARK 465 HIS A 52 REMARK 465 THR A 53 REMARK 465 PRO A 54 REMARK 465 LEU A 55 REMARK 465 SER A 168 REMARK 465 LYS A 169 REMARK 465 TRP A 170 REMARK 465 ARG A 171 REMARK 465 MET A 172 REMARK 465 MET A 173 REMARK 465 SER A 174 REMARK 465 LEU A 175 REMARK 465 SER A 176 REMARK 465 GLN A 177 REMARK 465 SER A 178 REMARK 465 ARG A 179 REMARK 465 SER A 180 REMARK 465 SER A 181 REMARK 465 LYS A 182 REMARK 465 SER A 183 REMARK 465 ALA A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 PRO A 200 REMARK 465 GLY A 201 REMARK 465 GLN A 202 REMARK 465 LYS A 203 REMARK 465 SER A 204 REMARK 465 ARG A 205 REMARK 465 MET B -15 REMARK 465 ASP B -14 REMARK 465 TYR B -13 REMARK 465 LYS B -12 REMARK 465 ASP B -11 REMARK 465 ASP B -10 REMARK 465 ASP B -9 REMARK 465 ASP B -8 REMARK 465 LYS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 ASN B 2 REMARK 465 GLY B 3 REMARK 465 GLU B 4 REMARK 465 ALA B 5 REMARK 465 HIS B 50 REMARK 465 ILE B 51 REMARK 465 HIS B 52 REMARK 465 THR B 53 REMARK 465 PRO B 54 REMARK 465 LEU B 55 REMARK 465 SER B 168 REMARK 465 LYS B 169 REMARK 465 TRP B 170 REMARK 465 ARG B 171 REMARK 465 MET B 172 REMARK 465 MET B 173 REMARK 465 SER B 174 REMARK 465 LEU B 175 REMARK 465 SER B 176 REMARK 465 GLN B 177 REMARK 465 SER B 178 REMARK 465 ARG B 179 REMARK 465 SER B 180 REMARK 465 SER B 181 REMARK 465 LYS B 182 REMARK 465 SER B 183 REMARK 465 ALA B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 GLY B 187 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 49 CG CD1 CD2 REMARK 470 HIS A 50 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 LEU B 56 CG CD1 CD2 REMARK 470 LYS B 61 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 21 88.21 -61.74 REMARK 500 SER A 25 -166.52 -169.52 REMARK 500 ARG A 41 35.63 71.49 REMARK 500 ASP A 146 36.33 -140.73 REMARK 500 PHE A 229 60.87 64.94 REMARK 500 ASN B 100 44.62 -108.12 REMARK 500 ASP B 146 41.06 -143.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2123 DISTANCE = 7.46 ANGSTROMS REMARK 525 HOH A2124 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH B2022 DISTANCE = 6.10 ANGSTROMS REMARK 525 HOH B2041 DISTANCE = 7.64 ANGSTROMS REMARK 525 HOH B2095 DISTANCE = 6.10 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 4-[4-(4-FLUOROPHENYL)-2-(4-METHANESULFINYLPHENYL)-1H-IMIDAZOL-5-YL]P REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SB2 A 1311 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SB2 B 1311 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AR2 RELATED DB: PDB REMARK 900 RIP2 KINASE CATALYTIC DOMAIN (1 - 310) REMARK 900 RELATED ID: 5AR3 RELATED DB: PDB REMARK 900 RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH AMP-PCP REMARK 900 RELATED ID: 5AR5 RELATED DB: PDB REMARK 900 RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BENZIMIDAZOLE REMARK 900 RELATED ID: 5AR7 RELATED DB: PDB REMARK 900 RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIARYL UREA REMARK 900 RELATED ID: 5AR8 RELATED DB: PDB REMARK 900 RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH REMARK 900 BIPHENYLSULFONAMIDE DBREF 5AR4 A 1 310 UNP O43353 RIPK2_HUMAN 1 310 DBREF 5AR4 B 1 310 UNP O43353 RIPK2_HUMAN 1 310 SEQADV 5AR4 MET A -15 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP A -14 UNP O43353 EXPRESSION TAG SEQADV 5AR4 TYR A -13 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LYS A -12 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP A -11 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP A -10 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP A -9 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP A -8 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LYS A -7 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLU A -6 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASN A -5 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LEU A -4 UNP O43353 EXPRESSION TAG SEQADV 5AR4 TYR A -3 UNP O43353 EXPRESSION TAG SEQADV 5AR4 PHE A -2 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLN A -1 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLY A 0 UNP O43353 EXPRESSION TAG SEQADV 5AR4 MET B -15 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP B -14 UNP O43353 EXPRESSION TAG SEQADV 5AR4 TYR B -13 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LYS B -12 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP B -11 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP B -10 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP B -9 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASP B -8 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LYS B -7 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLU B -6 UNP O43353 EXPRESSION TAG SEQADV 5AR4 ASN B -5 UNP O43353 EXPRESSION TAG SEQADV 5AR4 LEU B -4 UNP O43353 EXPRESSION TAG SEQADV 5AR4 TYR B -3 UNP O43353 EXPRESSION TAG SEQADV 5AR4 PHE B -2 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLN B -1 UNP O43353 EXPRESSION TAG SEQADV 5AR4 GLY B 0 UNP O43353 EXPRESSION TAG SEQRES 1 A 326 MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN LEU TYR SEQRES 2 A 326 PHE GLN GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU SEQRES 3 A 326 PRO THR ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR SEQRES 4 A 326 LEU SER ARG GLY ALA SER GLY THR VAL SER SER ALA ARG SEQRES 5 A 326 HIS ALA ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU SEQRES 6 A 326 HIS ILE HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP SEQRES 7 A 326 VAL LEU ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SEQRES 8 A 326 SER TYR ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO SEQRES 9 A 326 GLU PHE LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SEQRES 10 A 326 SER LEU ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO SEQRES 11 A 326 ASP VAL ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU SEQRES 12 A 326 ILE ALA LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO SEQRES 13 A 326 PRO LEU LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU SEQRES 14 A 326 LEU ASP ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY SEQRES 15 A 326 LEU SER LYS TRP ARG MET MET SER LEU SER GLN SER ARG SEQRES 16 A 326 SER SER LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR SEQRES 17 A 326 MET PRO PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG SEQRES 18 A 326 ALA SER ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE SEQRES 19 A 326 THR TRP GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP SEQRES 20 A 326 VAL THR ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN SEQRES 21 A 326 GLY HIS ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR SEQRES 22 A 326 ASP ILE PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SEQRES 23 A 326 SER GLY TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE SEQRES 24 A 326 LEU LYS CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR SEQRES 25 A 326 PHE GLU GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU SEQRES 26 A 326 LYS SEQRES 1 B 326 MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN LEU TYR SEQRES 2 B 326 PHE GLN GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU SEQRES 3 B 326 PRO THR ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR SEQRES 4 B 326 LEU SER ARG GLY ALA SER GLY THR VAL SER SER ALA ARG SEQRES 5 B 326 HIS ALA ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU SEQRES 6 B 326 HIS ILE HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP SEQRES 7 B 326 VAL LEU ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SEQRES 8 B 326 SER TYR ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO SEQRES 9 B 326 GLU PHE LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SEQRES 10 B 326 SER LEU ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO SEQRES 11 B 326 ASP VAL ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU SEQRES 12 B 326 ILE ALA LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO SEQRES 13 B 326 PRO LEU LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU SEQRES 14 B 326 LEU ASP ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY SEQRES 15 B 326 LEU SER LYS TRP ARG MET MET SER LEU SER GLN SER ARG SEQRES 16 B 326 SER SER LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR SEQRES 17 B 326 MET PRO PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG SEQRES 18 B 326 ALA SER ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE SEQRES 19 B 326 THR TRP GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP SEQRES 20 B 326 VAL THR ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN SEQRES 21 B 326 GLY HIS ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR SEQRES 22 B 326 ASP ILE PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SEQRES 23 B 326 SER GLY TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE SEQRES 24 B 326 LEU LYS CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR SEQRES 25 B 326 PHE GLU GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU SEQRES 26 B 326 LYS HET SB2 A1311 27 HET SB2 B1311 27 HETNAM SB2 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H- HETNAM 2 SB2 IMIDAZOL-4-YL]-PYRIDINE FORMUL 3 SB2 2(C21 H16 F N3 O S) FORMUL 5 HOH *220(H2 O) HELIX 1 1 PRO A 14 HIS A 16 5 3 HELIX 2 2 LEU A 56 ALA A 73 1 18 HELIX 3 3 SER A 102 ARG A 109 1 8 HELIX 4 4 ALA A 117 ASN A 137 1 21 HELIX 5 5 LYS A 148 GLN A 150 5 3 HELIX 6 6 PRO A 194 TYR A 198 5 5 HELIX 7 7 LYS A 209 ARG A 225 1 17 HELIX 8 8 ASN A 234 GLN A 244 1 11 HELIX 9 9 HIS A 261 TRP A 273 1 13 HELIX 10 10 ASN A 276 ARG A 280 5 5 HELIX 11 11 SER A 282 THR A 296 1 15 HELIX 12 12 GLU A 298 LYS A 310 1 13 HELIX 13 13 PRO B 14 HIS B 16 5 3 HELIX 14 14 ASP B 57 ALA B 73 1 17 HELIX 15 15 SER B 102 ARG B 109 1 8 HELIX 16 16 ALA B 117 ASN B 137 1 21 HELIX 17 17 LYS B 148 GLN B 150 5 3 HELIX 18 18 THR B 189 MET B 193 5 5 HELIX 19 19 PRO B 194 TYR B 198 5 5 HELIX 20 20 LYS B 209 ARG B 225 1 17 HELIX 21 21 ASN B 234 GLY B 245 1 12 HELIX 22 22 HIS B 261 TRP B 273 1 13 HELIX 23 23 ASN B 276 ARG B 280 5 5 HELIX 24 24 SER B 282 ARG B 295 1 14 HELIX 25 25 GLU B 298 LYS B 310 1 13 SHEET 1 AA 2 CYS A 7 ALA A 9 0 SHEET 2 AA 2 CYS B 7 ALA B 9 -1 O SER B 8 N SER A 8 SHEET 1 AB 5 LEU A 18 ARG A 26 0 SHEET 2 AB 5 THR A 31 HIS A 37 -1 O VAL A 32 N LEU A 24 SHEET 3 AB 5 GLN A 43 HIS A 48 -1 O VAL A 44 N ALA A 35 SHEET 4 AB 5 LEU A 91 GLU A 96 -1 O ILE A 93 N LYS A 47 SHEET 5 AB 5 ILE A 81 ASN A 86 -1 N LEU A 82 O VAL A 94 SHEET 1 AC 2 ILE A 152 LEU A 154 0 SHEET 2 AC 2 VAL A 160 ILE A 162 -1 O LYS A 161 N LEU A 153 SHEET 1 BA 5 LEU B 18 ARG B 26 0 SHEET 2 BA 5 THR B 31 HIS B 37 -1 O VAL B 32 N LEU B 24 SHEET 3 BA 5 GLN B 43 HIS B 48 -1 O VAL B 44 N ALA B 35 SHEET 4 BA 5 PHE B 90 GLU B 96 -1 O ILE B 93 N LYS B 47 SHEET 5 BA 5 ILE B 81 GLU B 87 -1 N LEU B 82 O VAL B 94 SHEET 1 BB 2 ILE B 152 LEU B 154 0 SHEET 2 BB 2 VAL B 160 ILE B 162 -1 O LYS B 161 N LEU B 153 CISPEP 1 THR A 139 PRO A 140 0 3.43 CISPEP 2 THR B 139 PRO B 140 0 3.85 SITE 1 AC1 15 ARG A 26 VAL A 32 ALA A 45 LYS A 47 SITE 2 AC1 15 GLU A 66 LEU A 70 ILE A 93 THR A 95 SITE 3 AC1 15 GLU A 96 TYR A 97 MET A 98 GLN A 150 SITE 4 AC1 15 LEU A 153 ASP A 164 HOH A2122 SITE 1 AC2 13 ARG B 26 ALA B 45 LYS B 47 GLU B 66 SITE 2 AC2 13 LEU B 70 ILE B 93 THR B 95 GLU B 96 SITE 3 AC2 13 MET B 98 LEU B 153 ASP B 164 HOH B2011 SITE 4 AC2 13 HOH B2094 CRYST1 131.217 131.217 106.904 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007621 0.004400 0.000000 0.00000 SCALE2 0.000000 0.008800 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009354 0.00000